http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
임광세 ( Kwang Sei Lim ),오세종 ( Se Jong Oh ),박동준 ( Dong June Park ),임지영 ( Jee Young Imm ) 한국유가공기술과학회 2015 한국유가공기술과학회지 Vol.33 No.2
Milk mineral, which is also called milk calcium, was recovered from concentrated skim milk ultrafiltration permeate (CUFP). Lactose, the major constituent of CUFP, was crystallized by the addition of ethanol; lactose precipitation was observed to increase as the ratio of CUFP to ethanol increased. The calcium content of CUFP remained constant at a CUFP to ethanol ratio of 1:2, while it significantly decreased at a CUFP to ethanol ratio of 1:4. When ethanol (95%, v/v) was reused to precipitate lactose out of CUFP, 85% of the initial lactose precipitated out, while 82% of calcium remained soluble in the CUFP after storage for 24 h.
프로바이오틱스가 생산하는 생리활성 물질의 장내 유해균 억제 효과
임광세 ( Kwang Sei Lim ),( Mansel W. Griffiths ),박동준 ( Dong June Park ),오세종 ( Se Jong Oh ) 한국유가공기술과학회 2014 Journal of Dairy Science and Biotechnology (JMSB) Vol.32 No.2
시장에는 프로바이오틱스를 포함한 무수히 많은 제품이 판매되고 있는데, 우리에게 어떤 이로운 점을 줄 수 있는지 궁금해 한 적이 있었을 것이다. 프로바이오틱스는 기본적인 영양 측면을 배제하고, 우리가 유효한 양을 섭취하였을 때 건강상의 이점을 주는 살아있는 미생물로 정의된다. 프로바이오틱스는 유용하고 건강에 좋은 미생물로도 불려지고 있으며, 다음과 같은 다섯 가지 측면에서 건강 기능성이있는 것으로 강조되어 왔는데, 1) 대장암 및 IBS와 같은 다른 대장(결장)관련 질병의 발병율 감소, 2) 면역 시스템의 촉진, 3) 항고혈압 및 항콜레스테롤 작용, 4) 장내세균에 작용하는 항생제의 효과를 경감시키고, 5) 위장관 감염을 예방시키는 점이다. 그러나 이러한 건강기능 작용들에 대한 과학적인 근거가 충분히 구축되어 있지는 않아, 유럽식품 위생위원회(Euroupe Food Safety Authority)는 항생제 투여에 따른 설사증상의 완화와 같은 건강기능 표시를 금지하고 있어, 프로바이오틱스의 작용기전에 대한 연구가 필요 한 시점이라 하겠다. There is a burgeoning number of products on the market that contain probiotics, but do they do you any good? What exactly are probiotics? They have been defined as living organisms that, when ingested in sufficient quantities, provide health benefits beyond basic nutrition. They are often referred to as "friendly bacteria" or "good bacteria." Probiotics have been claimed, amongst other things, to (i) reduce the incidence of colon cancer and other diseases of the colon, such as IBS, (ii) stimulate the immune system, (iii) have anti-hypertensive and anti-cholesterolemic properties, (iv) mitigate against the effect of antibiotics on the intestinal microbiota, and (v) protect against gastrointestinal infections. However, the scientific basis for many of these claims is not well-established. Indeed, the European Food Safety Authority has denied the use of several health claims associated with probiotics, particularly those related to mitigation of diarrhea following consumption of antibiotics. Thus, there is a need for research on the mechanisms of action of probiotics. We have been mainly interested in the use of probiotics to control enteric infections. There are several possible modes of action to explain how probiotics may protect the host from enteric pathogens, including competitive exclusion and immunomodulation. We have shown that probiotics produce bioactive molecules that interfere with bacterial cell-cell communication (also called quorum sensing), and this results in a down-regulation of virulence genes that are responsible for attachment of the pathogen to the gastrointestinal epithelium. These bioactive molecules act on a variety of bacteria, including enterohemorrhagic and enterotoxigenic Escherichia coli, Salmonella, Clostridium difficile and Clostridium perfringens, and there is evidence that they can inhibit the formation of biofilms by Listeria monocytogenes. These bioactive molecules, which are peptidic in nature, can exert their effects not only in vitro but also in vivo, and we have shown that they mitigate against E. coli O157:H7 and Salmonella in mice and Salmonella and E. coli K88 infections in pigs. They can be delivered in foods such as yoghurt and maintain their activity.
Lactobacillus rhamnosusGG의 면역조절작용과 장내 정착성
타다오사이토 ( Tadao Saito ),임광세 ( Kwang Sei Lim ) 한국유가공기술과학회 2012 Journal of Dairy Science and Biotechnology (JMSB) Vol.30 No.1
Lactobacillus rhamnosus GG(ATCC 53103) is one of the best researched probiotic strains in the world. Studies in children have shown that Lactobacillus rhamnosus GG effectively prevents early atopic disease in patients with high risk. The active molecules associated with the immunostimulatory sequence and anti-allergy effects of L. rhamnosus GG have not yet been identified. Unmethylated CpG motifs in bacterial DNA have a mitogenic effect in mouse immune cells, CpG-containing ISS oligodeoxynucleotides are potent Th1 adjuvants, effective in both preventing and reversing Th2-biased immune deviation in allergy models. The genomic DNA of L. rhamnosus GG is a potent inducer of murine B cell and dendritic cell immunoactivation. In L. rhamnosus GG genomic DNA, ID35 shows high activity in ISS assays in both mice and humans. The effects of ID35 result from a unique TTTCGTT motif located at its 5`-end, and its effects are comparable with murine prototype CpG 1826. L. rhamnosus GG is known to secrete proteinaceous pili encoded by the spaCBA gene cluster. The presence of pili structures may be essential for its adhesion to human intestinal mucus, explaining the prolonged duration of intestinal residence of this bacterium, compared to that of non-piliated lactobacilli.
이지애 ( Je Ae Lee ),전기훈 ( Gi Hoon Jeun ),임광세 ( Kwang Sei Lim ),오세종 ( Se Jong Oh ),박동준 ( Dong June Park ),임지영 ( Jee Young Imm ) 한국유가공기술과학회 2014 Journal of Dairy Science and Biotechnology (JMSB) Vol.32 No.2
요구르트 분말의 수요는 꾸준히 증가하고 있으나, 요구르트 분말 제품은 ``발효유 분말"의 법적 기준(>유고형분 85%)을 총족시키지 못하고, 대부분의 제품 유형은 당류가공품 또는 기타 가공품에 해당하였다. 분말 요구르트 제품 중에는 유산균이 전혀 검출되지 않은 제품도 상당수 있었으며, 일부의 제품을 제외하고는 건강 증진 효과는 기대하기 어려운 것으로 확인되었다. 제품의 수화특성도 상당한 차이를 보였으며, 제품 내 점증제 등의 함유 비율이 상이하여동일한 농도로 환원시킨 경우, 점도에 큰 차이를 보였다. 결론적으로 성분규격이 명확치 않은 저가의 수입산 원료를 일부 첨가하여 유성분(유단백질)이나 유산균이 전혀 없는 제품을 요구르트 분말이라고 표기해서 판매되는 제품은 소비자의 오해를 일으킬 수 있으므로 법적 규격의 정비와 홍 보가 필요할 것으로 판단된다. Quality characteristics of commercial yoghurt powder products marketed in Korea were compared. According to the product type classification, no product met the product identity of "fermented milk powder" (six were identified as "other processed product" and nine as "sugar product"). Titratable acidity of products (10%, w/v) varied from 0.11 to 0.82% while numbers of lactic acid bacteria varied from 0 to 1.4×108 CFU/g. There were significant differences in hydration properties and viscosity of yoghurt powder products. Some regulations are required to avoid consumer misunderstanding of beneficial health effects of yoghurt powder products.
발효유제품에서 Lactobacillus rhamnosus GG의 생육 특성
방미선 ( Mi Seon Bang ),정안나 ( An Na Jeong ),박동준 ( Dong June Park ),임광세 ( Kwang Sei Lim ),오세종 ( Se Jong Oh ) 한국유가공기술과학회 2015 Journal of Dairy Science and Biotechnology (JMSB) Vol.33 No.1
Yogurt is a product of the acidic fermentation of milk, which affects the survival of lactic acid bacteria (LAB). The aim of this present study was to examine the survival and acid stress response of Lactobacillus rhamnosus GG to low pH environment. The survival of LAB in commercial yogurt was measured during long-term storage. The enumeration of viable cells of LAB was determined at 15-day intervals over 52-weeks at 5℃. L. acidophilus, L. casei, and Bifidobacterium spp. showed low viability. However, L. rhamnosus GG exhibited excellent survival throughout the refrigerated storage period. At the end of 52-weeks, L. rhamnosus GG survived 7.0 log10 CFU/mL. F0F1 ATPase activity in L. rhamnosus GG at pH 4.5 was also evaluated. The ATPase activities of the membranes were higher when exposed at pH 4.5 for 24 h. The survival of L. rhamnosus GG was attributable to the induction in F0F1 ATPase activity. In addition, the mRNA expression levels of acid stress-inducible genes at low pH were investigated by qRT-PCR. clpC and clpE genes were up-regulated after 1 h, and atpA and dnaK genes were up-regulated after 24 h of incubation at pH 4.5. These genes could enhance the survival of L. rhamnosus GG in the acidic condition. Thus, the modulation of the enzymes or genes to assist the viability of LAB in the low pH environment is thought to be important.
Bacillus subtilis Y3-7 배양액의 α-glucosidase 활성 억제 효과
명길선(Kil-Sun Myoung),허건(Gun Heo),윤석영(Suck-Yong Yoon),심재중(Jae-Jung Shim),이정희(Jung-Hee Lee),임광세(Kwang-Sei Lim),허철성(Chul-Sung Huh) 한국식품과학회 2008 한국식품과학회지 Vol.40 No.5
본 연구에서는 전통 발효 식품에서 분리한 B. subtilis Y3-7 균주의 배양액이 α-glucosidase의 활성에 미치는 영향을 살펴보았다. B. subtilis Y3-7 균주를 TSB 배지에 30시간 이상 배양한 배양액은 1.62 ㎎/mL의 농도로 yeast α-glucosidase의 활성을 50%까지 저해할 수 있었다. 또한 효소학적 분석을 통해 이것이 배양액 내 물질이 효소의 기질과 경쟁적으로 작용하여 억제효과가 나타남을 확인하였다. B. subtilis Y3-7 균주의 배양액은 yeast 뿐만 아니라 실험동물의 장내 α-glucosidase의 활성에도 영향을 미쳐 당부하에 따른 급격한 혈당상승을 억제할 수 있었다. 이와 같은 결과로 보아 대량배양이 가능한 B. subtilis Y3-7을 통해 탄수화물 흡수에 중요한 역할을 하는 α-glucosidase 활성억제 물질을 얻음으로써 항당뇨 물질의 안정적인 생산이 기대되는 바이다. Culture broth of Bacillus subtilis Y3-7 in tryptic soy broth (TSB) isolated from Korean traditional fermented food was evaluated for the inhibition of α-glucosidase. The results of in vitro studies using the yeast α-glucosidase demonstrated that the culture broth exerted inhibitory effects on α-glucosidase with IC?? value of 1.62 ㎎/mL, and functioned as a competitive inhibitor. Furthermore, the culture broth of B. subtilis Y3-7 significantly improved glucose tolerance in normal and streptozotocin-induced diabetic mice. The blood glucose levels in the mice receiving sucrose supplementation in the culture broth (1 g/㎏, 2 g/㎏) were measured at 48.7%, which corresponded to 22.2% of the levels measured in the control mice. These results indicated that the culture broth of B. subtilis Y3-7 in TSB might be considered as a useful compound for the preparation of functional foods for diabetic patients.